NYSE:HLN • US4055521003
This HLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
We assign a fundamental rating of 5 out of 10 to HLN. HLN was compared to 193 industry peers in the Pharmaceuticals industry. While HLN has a great profitability rating, there are some minor concerns on its financial health. HLN has a valuation in line with the averages, but it does not seem to be growing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.11% | ||
| ROE | 10.15% | ||
| ROIC | 6.91% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.36% | ||
| PM (TTM) | 15.11% | ||
| GM | 64.69% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.88 | ||
| Altman-Z | 2.51 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.71 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.9 | ||
| Fwd PE | 17.66 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.02 | ||
| EV/EBITDA | 14.43 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.86% |
10.03
-0.04 (-0.4%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.86% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.9 | ||
| Fwd PE | 17.66 | ||
| P/S | 3.02 | ||
| P/FCF | 15.02 | ||
| P/OCF | 12.66 | ||
| P/B | 2.03 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.43 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.11% | ||
| ROE | 10.15% | ||
| ROCE | 8.9% | ||
| ROIC | 6.91% | ||
| ROICexc | 7.26% | ||
| ROICexgc | 251.94% | ||
| OM | 22.36% | ||
| PM (TTM) | 15.11% | ||
| GM | 64.69% | ||
| FCFM | 20.14% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.88 | ||
| Debt/EBITDA | 2.75 | ||
| Cap/Depr | 114.72% | ||
| Cap/Sales | 3.74% | ||
| Interest Coverage | 6.91 | ||
| Cash Conversion | 93.21% | ||
| Profit Quality | 133.23% | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 2.51 |
ChartMill assigns a fundamental rating of 5 / 10 to HLN.
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 20.9 and the Price/Book (PB) ratio is 2.03.
The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 36.71%.